GlassScriptPhysician profile
Robert W Murdock
NPI 1124461223
$11,948.75
in general payments reported to CMS, 2019-2025
27 companies · $822 in 2025
The $822 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,751 · 2020: $848 · 2021: $958 · 2022: $620 · 2023: $1,404 · 2024: $4,547 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,967 · Travel and Lodging: $2,640 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,967.35 |
| Travel and Lodging | $2,639.60 |
| Education | $165.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,262.18 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Pulseselect |
| Boston Scientific Corporation | $2,352.44 | 2019-2025 | Farapulse, Rhythmia Mapping System, Versacross Large Access Solution |
| Abbott Laboratories | $1,413.94 | 2019-2025 | Ensite, Ensite Precision, Assurity |
| Medical Device Business Services, INC. | $978.34 | 2020-2024 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $599.71 | 2019-2021 | |
| Biosense Webster, INC. | $466.04 | 2021-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $307.85 | 2019-2024 | Camzyos |
| Impulse Dynamics (USA) INC. | $196.90 | 2025 | Optimizer |
| Biotronik INC. | $176.70 | 2020-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Rivacor 7 Dr-T |
| Amgen INC. | $162.60 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $153.43 | 2020-2021 | |
| Abiomed | $148.19 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $141.74 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $113.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $100.78 | 2019-2024 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $99.64 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.51 | 2019 | |
| Merck Sharp & Dohme LLC | $25.51 | 2023 | Verquvo |
| Pfizer INC. | $25.27 | 2025 | |
| Heartflow, INC. | $21.82 | 2025 | |
| Shockwave Medical, INC | $20.97 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $19.74 | 2019 | |
| Nuwellis, INC. | $18.56 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $17.55 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $16.66 | 2024 | Amvuttra |
| Cordis US Corp. | $13.51 | 2024 | Mynx Control |
| Terumo Medical Corporation | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.